A team led by investigators at Massachusetts General Hospital (MGH) recently developed an artificial intelligence - based method to predict which patients are most likely to experience a recurrence and are therefore expected to benefit from aggressive treatment.
Through the Horizon Europe Programme (Artificial Intelligence and Robotics), the AI4Europe project, led by Irish University College Cork (UCC) has been awarded €9 million to develop the platform.